Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics

Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and have been linked with the presence of pre-diabetes and type 2 diabetes. The financial terms of the licensing agreement were not disclosed.  

"The biomarkers were discovered using Intrinsic Bioprobes' unique Mass Spectrometric Immunoassay technologies," says Urban Kiernan, Ph.D., the Director of Biomarker Discovery at Intrinsic Bioprobes. "The biomarkers were extensively tested and shown to have statistically significant clinical sensitivities and specificities in differentiating subjects with pre- and type-2 diabetes from healthy controls," adds Kiernan.

The initial discovery of the biomarkers was supported in part by a 5-year, $2M grant from the National Institutes of Health to Intrinsic Bioprobes, in collaboration with researchers from Yale University. "Diabetes is a complex disease, and novel markers could help us understand it better and identify disease subtypes," says Dr. Salvatore Sechi, program director at the National Institute of Diabetes and Digestive and Kidney Diseases. "We are pleased that the scientific discoveries made through the Small Business Technology Transfer Program are of interest to a large diagnostic company."

Source:

Intrinsic Bioprobes, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ortho-Clinical Diagnostics, Inc.. (2019, June 19). Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics. News-Medical. Retrieved on August 17, 2019 from https://www.news-medical.net/news/20100122/Intrinsic-Bioprobes-licenses-diabetes-biomarkers-to-Ortho-Clinical-Diagnostics.aspx.

  • MLA

    Ortho-Clinical Diagnostics, Inc.. "Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics". News-Medical. 17 August 2019. <https://www.news-medical.net/news/20100122/Intrinsic-Bioprobes-licenses-diabetes-biomarkers-to-Ortho-Clinical-Diagnostics.aspx>.

  • Chicago

    Ortho-Clinical Diagnostics, Inc.. "Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics". News-Medical. https://www.news-medical.net/news/20100122/Intrinsic-Bioprobes-licenses-diabetes-biomarkers-to-Ortho-Clinical-Diagnostics.aspx. (accessed August 17, 2019).

  • Harvard

    Ortho-Clinical Diagnostics, Inc.. 2019. Intrinsic Bioprobes licenses diabetes biomarkers to Ortho-Clinical Diagnostics. News-Medical, viewed 17 August 2019, https://www.news-medical.net/news/20100122/Intrinsic-Bioprobes-licenses-diabetes-biomarkers-to-Ortho-Clinical-Diagnostics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
FDA clears Ortho Clinical Diagnostics’ VITROS XT MicroSlides